Human Longevity

Human Longevity Inc. is a private, commercial-stage company pioneering a data-driven, preventative healthcare model focused on longevity. Its business is built on a proprietary technology platform that integrates multi-omics data, advanced imaging, and AI to identify health risks early, particularly for cancer, cardiovascular, metabolic, and neurodegenerative diseases. The company generates revenue through its direct-to-consumer Executive Health Program, backed by a $1 million cancer prevention pledge, and is expanding its clinic footprint from San Diego and San Francisco globally. Leadership combines scientific pedigree from Dr. J. Craig Venter with commercial execution under Executive Chairman Dr. Wei-Wu He.

Integrated multimodal platform combining Whole Genome Sequencing, Whole Body MRI, and advanced blood biomarkers (proteomics, metabolomics), analyzed with AI/ML on a large longitudinal health database for early disease detection and risk assessment.

HLI competes in the high-end concierge and executive health market against elite clinic networks (e.g., Mayo Clinic, Cleveland Clinic Executive Health) and a growing number of longevity-focused startups (e.g., Fountain Life, Health Nucleus). Its key differentiator is the deep integration of whole-genome sequencing and whole-body MRI with AI analytics, which few competitors match in a single offering.